CPHI [CHINA PHARMAS,] 8-K: (Original Filing)

[FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Participant: _______ Number of Restricted Shares granted:_______ ***** 2. Grant of Restricted Share Award . Vesting 3.1 _______________________________________ 3.3 If the Participants employment with thempany and/or its Subsidiaries terminates due to the Participant's death, Disability or Retirement, the Participant shall become 100% vested] [FORM OF NON-QUALIFIED STOCK OPTIONREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Optionee:________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ ***** 2. Grant of Option . 3. No Dividends Equivalents . 4. Exercise of this Option . 4.1 4.2 4.3] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable him to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany]

By | 2016-02-07T22:57:57+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

WH [WSP] 6-K: (Original Filing)

[Contact: WSP Holdings Limited CCG Investor Relations, Inc. Ms. Judy Zhu, IR Director Ms. Elaine Ketchmere, Partner Phone: +86-510-8536-0401 Phone: +1-310-954-1345 (Los Angeles) E-mail: info@wsphl.com E-mail: elaine.ketchmere@ccgir.com http://www.wsphl.com http://www.ccgirasia.com Mr. Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: crocker.coulson@ccgir.com WSP Holdings Appoints New Independent Director Wuxi, China, June 1 , 2011 — Since 2001 Mr. Michael Muhan Liu has been] [WSP HOLDINGS LIMITED By : Name : Longhua Piao Title : Chairman and Chief Executive Officer 2 Description______________________________________________ 99.1 Press release]

CPHI [CHINA PHARMAS,] 8-K: FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN

[FORM OF RESTRICTED SHARE AWARDREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Participant: _______ Number of Restricted Shares granted:_______ ***** 2. Grant of Restricted Share Award . Vesting 3.1 _______________________________________ 3.3 If the Participants employment with thempany and/or its Subsidiaries terminates due to the Participant's death, Disability or Retirement, the Participant shall become 100% vested] [FORM OF NON-QUALIFIED STOCK OPTIONREEMENT 2010 LONG-TERMENTIVE PLAN OF CHINA PHARMAS, ***** Optionee:________ Per Share Exercise Price: $________ Number of Option Shares subject to this Option: ________ ***** 2. Grant of Option . 3. No Dividends Equivalents . 4. Exercise of this Option . 4.1 4.2 4.3] [EMPLOYMENTREEMENT WITNESSETH: WHEREAS, thempany is engaged in the business of develop, manufacture, and marketecialty pharmaceutical products in China (the business); and WHEREAS, Employee has represented that he has the experience, background and expertise necessary to enable him to be thempanys Chief Financial Officer; and WHEREAS, based on such representation, and thempanys reasonable due diligence, thempany]

By | 2016-02-07T22:58:51+00:00 June 1st, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

WH [WSP] 6-K: Contact: WSP Holdings Limited CCG Investor Relations, Inc.

[Contact: WSP Holdings Limited CCG Investor Relations, Inc. Ms. Judy Zhu, IR Director Ms. Elaine Ketchmere, Partner Phone: +86-510-8536-0401 Phone: +1-310-954-1345 (Los Angeles) E-mail: info@wsphl.com E-mail: elaine.ketchmere@ccgir.com http://www.wsphl.com http://www.ccgirasia.com Mr. Crocker Coulson, President Phone: +1-646-213-1915 (New York) Email: crocker.coulson@ccgir.com WSP Holdings Appoints New Independent Director Wuxi, China, June 1 , 2011 — Since 2001 Mr. Michael Muhan Liu has been] [WSP HOLDINGS LIMITED By : Name : Longhua Piao Title : Chairman and Chief Executive Officer 2 Description______________________________________________ 99.1 Press release]

Skip to toolbar